Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or p…
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Estimated
~$10 – $7,500
CSL BehringNCT03684018
Phase 3
Multicenter, Prospective, Double-Blinded, Parallel Group, Randomized Phase III Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Estimated
~$10 – $8,750
OctapharmaNCT04929236